Literature DB >> 27268256

Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndrome.

Patrick J Gleeson1, Valerie Wilson2, Thomas E Cox3, Seema D Sharma3, Kate Smith-Jackson3, Lisa Strain2, David Lappin1, Teresa McHale1, David Kavanagh3, Timothy H J Goodship4.   

Abstract

Chromosomal rearrangements affecting the genes encoding complement factor H and the factor H related proteins have been described in aHUS patients. To date such disorders have not been described in other aHUS associated genes. We describe here a heterozygous 875,324bp deletion encompassing the gene (CFI) encoding complement factor I and ten other genes. The index case presented with aHUS and did not recover renal function. No abnormalities were detected on Sanger sequencing of CFI but a low factor I level led to a multiplex ligation-dependent probe amplification assay being undertaken. This showed a complete heterozygous deletion of CFI. The extent of the deletion and the breakpoint was defined. In the Newcastle aHUS cohort we have identified and report here 32 different CFI variants in 56 patients but to date this is the only deletion that we have identified. This finding although rare does suggest that screening for chromosomal rearrangements affecting CFI should be undertaken in all aHUS patients particularly if the factor I level is unexplainably low.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Atypical haemolytic uraemic syndrome; Chromosomal rearrangement; Complement; Factor I; Genetic variants

Mesh:

Substances:

Year:  2016        PMID: 27268256     DOI: 10.1016/j.imbio.2016.05.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

Review 1.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

2.  An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access.

Authors:  Amy V Jones; Darin Curtiss; Claire Harris; Tom Southerington; Marco Hautalahti; Pauli Wihuri; Johanna Mäkelä; Roosa E Kallionpää; Enni Makkonen; Theresa Knopp; Arto Mannermaa; Erna Mäkinen; Anne-Mari Moilanen; Tongalp H Tezel; Nadia K Waheed
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

3.  Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.

Authors:  Rachel C Challis; Troels Ring; Yaobo Xu; Edwin K S Wong; Oliver Flossmann; Ian S D Roberts; Saeed Ahmed; Michael Wetherall; Giedrius Salkus; Vicky Brocklebank; Julian Fester; Lisa Strain; Valerie Wilson; Katrina M Wood; Kevin J Marchbank; Mauro Santibanez-Koref; Timothy H J Goodship; David Kavanagh
Journal:  J Am Soc Nephrol       Date:  2016-12-14       Impact factor: 10.121

4.  Hemolytic Uremic Syndrome in Pregnancy and Postpartum.

Authors:  Alexandra Bruel; David Kavanagh; Marina Noris; Yahsou Delmas; Edwin K S Wong; Elena Bresin; François Provôt; Vicky Brocklebank; Caterina Mele; Giuseppe Remuzzi; Chantal Loirat; Véronique Frémeaux-Bacchi; Fadi Fakhouri
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-08       Impact factor: 8.237

Review 5.  Diseases of complement dysregulation-an overview.

Authors:  Edwin K S Wong; David Kavanagh
Journal:  Semin Immunopathol       Date:  2018-01-11       Impact factor: 9.623

6.  Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.

Authors:  Vicky Brocklebank; Sally Johnson; Thomas P Sheerin; Stephen D Marks; Rodney D Gilbert; Kay Tyerman; Meredith Kinoshita; Atif Awan; Amrit Kaur; Nicholas Webb; Shivaram Hegde; Eric Finlay; Maggie Fitzpatrick; Patrick R Walsh; Edwin K S Wong; Caroline Booth; Larissa Kerecuk; Alan D Salama; Mike Almond; Carol Inward; Timothy H Goodship; Neil S Sheerin; Kevin J Marchbank; David Kavanagh
Journal:  Kidney Int       Date:  2017-07-24       Impact factor: 10.612

7.  Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.

Authors:  Vicky Brocklebank; Gurinder Kumar; Alexander J Howie; Jayanthi Chandar; David V Milford; Janet Craze; Jonathan Evans; Eric Finlay; Michael Freundlich; Daniel P Gale; Carol Inward; Martin Mraz; Caroline Jones; William Wong; Stephen D Marks; John Connolly; Bronte M Corner; Kate Smith-Jackson; Patrick R Walsh; Kevin J Marchbank; Claire L Harris; Valerie Wilson; Edwin K S Wong; Michal Malina; Sally Johnson; Neil S Sheerin; David Kavanagh
Journal:  Kidney Int       Date:  2020-02-28       Impact factor: 10.612

8.  Prevalence and phenotype associations of complement factor I mutations in geographic atrophy.

Authors:  Adnan H Khan; Janice Sutton; Angela J Cree; Samir Khandhadia; Gabriella De Salvo; John Tobin; Priya Prakash; Rashi Arora; Winfried Amoaku; Peter Charbel Issa; Robert E MacLaren; Paul N Bishop; Tunde Peto; Quresh Mohamed; David H Steel; Sobha Sivaprasad; Clare Bailey; Geeta Menon; David Kavanagh; Andrew J Lotery
Journal:  Hum Mutat       Date:  2021-06-29       Impact factor: 4.700

9.  Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration.

Authors:  Thomas M Hallam; Kevin J Marchbank; Claire L Harris; Clive Osmond; Victoria G Shuttleworth; Helen Griffiths; Angela J Cree; David Kavanagh; Andrew J Lotery
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

10.  Primary pneumococcal peritonitis can be the first presentation of a familial complement factor I deficiency1.

Authors:  S Ugrinovic; H Firth; D Kavanagh; T Gouliouris; P Gurugama; H Baxendale; P J Lachmann; D Kumararatne; E Gkrania-Klotsas
Journal:  Clin Exp Immunol       Date:  2020-07-24       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.